Recent Finacing
Recent Raise
Retrotope is a Los Altos-based biopharma developing patented D-PUFA compounds (lead RT001), an oral membrane-incorporating agent that prevents lipid peroxidation and is in clinical trials for multiple neurodegenerative disorders.
